July 25, 2017
Direction must be questioned and at risk for reversal
Critical indications ahead of “our” universe’s open!
This is a limited-time preview of RegMed Investor's morning call. To get the pre-open briefing, plus daily access of the happenings and realities of “our” universe ……SUBSCRIBE!
Don’t ignore this …
June 1, 2017
Calling out the recent 10-Q page 17’s paragraph re a 24 page legal filing - this is what BSTG did NOT want investors to know or read!
May 31, 2017
CYTX jumps +$0.04 or +4.08% to $1.01 with 113.05 shares traded – it’s still ONLY an OPTION - something is better than ... nothing!
January 28, 2017
What difference does a $1.00 subscription a day, $100.00 a quarter abating the lack of a portfolio ... enema!
July 23, 2017
The IBB ended up + 0.61% with the XBI +0.79% while the IWM was down -0.45% with the XLV -0.11% and the VIX was down -2.30%
There is a lot of oil on the water keeping the waves down ...
Start worrying about Q2 results, cash positions and spending and pricing depreciation pre the announcements that start 8/1 with Athersys (ATHX)
Read more because … unless you know what happened today; it is hard to formulate a perspective for tomorrow!
It’s called premium content for a reason … I define insight from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!
Others don’t even come close!
I answer one question, in which company should investors commit and keep their money.
June 27, 2017
On track for top-line 1 year powered data and potential BLA filing in Q3/18 BLA to the FDA shortly thereafter and, if approved, launching NeoCart in the second half of 2019
June 26, 2017
BLUE closed down -$4.20 to $1.06.90 after Monday's -$0.90 or -0.80% to $111.10
June 20, 2017
SGMO closes UP +$0.25 to $8.20 and promptly dives -$0.70 or -8.54% to $7.50 SGMO prices 10 M shares at $7.25
The process of calling out our grading of covered companies to rank and review the facts in evidence together with analysis, opinion and objective recommendation.
5 hours 50 min ago
RegMed Investors’ (RMi) pre-open indications, let’m ride